Cargando…
Metformin Treatment Does Not Inhibit Growth of Pancreatic Cancer Patient-Derived Xenografts
There is currently tremendous interest in developing anti-cancer therapeutics targeting cell signaling pathways important for both cancer cell metabolism and growth. Several epidemiological studies have shown that diabetic patients taking metformin have a decreased incidence of pancreatic cancer. Th...
Autores principales: | Lipner, Matthew B., Marayati, Raoud, Deng, Yangmei, Wang, Xianxi, Raftery, Laura, O’Neil, Bert H., Yeh, Jen Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711922/ https://www.ncbi.nlm.nih.gov/pubmed/26760500 http://dx.doi.org/10.1371/journal.pone.0147113 |
Ejemplares similares
-
Hexokinase 2 promotes tumor growth and metastasis by regulating lactate production in pancreatic cancer
por: Anderson, Marybeth, et al.
Publicado: (2016) -
Focal Adhesion Kinase Inhibition Contributes to Tumor Cell Survival and Motility in Neuroblastoma Patient-Derived Xenografts
por: Stafman, Laura L., et al.
Publicado: (2019) -
Targeting High-Risk Neuroblastoma Patient-Derived Xenografts with Oncolytic Virotherapy
por: Quinn, Colin H., et al.
Publicado: (2022) -
The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor
por: Aye, Jamie M., et al.
Publicado: (2019) -
Metformin inhibits growth and prolactin secretion of pituitary prolactinoma cells and xenografts
por: Gao, Jun, et al.
Publicado: (2018)